StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Saturday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens boosted their price objective on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Stock Analysis on Veradigm
Veradigm Trading Down 1.1 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Stock Analyst Ratings and Canadian Analyst Ratings
- Best Defense Stocks in 2025… So Far
- How to Short Nasdaq: An Easy-to-Follow Guide
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- What Makes a Stock a Good Dividend Stock?
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
